Emma is a graduate student in Prof. Pam Silver’s lab and the Laboratory of Systems Pharmacology at Harvard Medical School. For most of her PhD, she has worked on engineering mammalian cells to produce novel steroids. Her current project uses proteomics to study the human innate immune response to DNA in the cytoplasm. Emma’s techniques are as eclectic as her interests; she has used CRISPR-Cas9, small molecule mass spectrometry, HPLC purification, NMR structure identification, protein structure modeling, and pharmacokinetics models in her research.
Emma graduated from Swarthmore College with a B.A. in Biochemistry in 2013. She earned High Honors in final exams for seminars in microbial metabolism, protein structure, and environmental chemistry. Her undergraduate thesis under Prof. Amy Vollmer studied E. coli with mutant Universal Stress Protein A variants. She used RNA microarrays to understand how their ethanol shock response was disrupted, segmenting the raw image files and analyzing the data in R herself. Emma entered the Chemical Biology PhD Program at Harvard University in 2013.